SCHEMBL2355124

SCHEMBL2355124

CCCCCCCC(=O)NC(CS)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 7/20 0.69
FAAH O00519 7/20 0.58
MEN1 O00255 1/20 0.58
MAPK1 P28482 1/20 0.58
KMT2A Q03164 1/20 0.58
SLC6A5 Q9Y345 1/20 0.55
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
PTGS2 P35354 1/20 0.52
THPO P40225 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
DNM1 Q05193 1/20 0.51
PLA2G2C Q5R387 1/20 0.51
EPHX2 P34913 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2349849 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL16190307 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL16190310 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL1672712 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL2355126 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL25187792 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL2349133 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL2353176 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL21291889 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A
SCHEMBL2349127 1.00 NOD1 (0.69) NOD1FAAHMEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187624-B2 Method of acylating amino acids and uses of N-acyl amino acid products NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2025-01-07 US disclosed
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2025-01-02 US disclosed
EP-3927684-B1 METHOD OF ACYLATING AMINO ACIDS AND USES OF N-ACYL AMINO ACID PRODUCTS NEWSOUTH INNOVATIONS PTY LTD (AU) 2024-12-18 EP disclosed
EP-4433093-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-09-25 EP disclosed
CN-118488855-A Solid composition comprising peptide or protein and acylated amino acid 阿道恰公司 2024-08-13 CN disclosed
EP-3257497-B1 ANTIOXIDANT AGENT, ANTIOXIDANT COSMETIC AND UV CARE COSMETIC BASED ON ENZYMATICALLY SYNTHESIZED GLYCOGEN OR AN ALPHA-AMYLASE DIGEST THEREOF EZAKI GLICO CO (JP) 2024-04-24 EP disclosed
EP-4299057-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-01-03 EP disclosed
US-20230183095-A1 METHOD OF ACYLATING AMINO ACIDS AND USES OF N-ACYL AMINO ACID PRODUCTS NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2023-06-15 US disclosed
WO-2023084118-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2023-05-19 WO disclosed
EP-4180060-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2023-05-17 EP disclosed
US-20070099888-A1 Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid AJINOMOTO CO., INC. (JP) 2007-05-03 US disclosed
US-6914075-B2 Cystine derivative and agent for suppressing activation of inflammatory factors AJINOMOTO CO., INC. (JP) 2005-07-05 US disclosed
EP-1500385-A1 METHOD OF FOAM STABILIZATION FOR FOAM COSMETIC Hakuto Co., Ltd (JP) 2005-01-26 EP disclosed
EP-1486193-A1 METHOD OF STABILIZING SILICONE OIL-CONTAINING COSMETIC COMPOSITION Hakuto Co., Ltd (JP) 2004-12-15 EP disclosed
US-20040156802-A1 Cosmetics or external preparations for skin AJINOMOTO CO., INC. (JP) 2004-08-12 US disclosed
US-20040059110-A1 Novel cystine derivative and agent for suppressing activation of inflammatory factors AJINOMOTO CO., INC. (JP) 2004-03-25 US disclosed
EP-1374831-A1 COMSETICS OR EXTERNAL PREPARAIOTNS FOR SKIN Ajinomoto Co., Inc. (JP) 2004-01-02 EP disclosed
EP-1364943-A1 NOVEL CYSTINE DERIVATIVES AND INHIBITORS FOR THE ACTIVATION OF INFLAMMATORY FACTORS Ajinomoto Co., Inc. (JP) 2003-11-26 EP disclosed
EP-0866684-A1 COSMETIC HAIR TREATMENT METHOD UNILEVER PLC (GB) 1998-09-30 EP disclosed
WO-1997022329-A1 COSMETIC HAIR TREATMENT METHOD UNILEVER PLC (GB) 1997-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059110-A1 Novel cystine derivative and agent for suppressing activation of inflammatory factors CTH, CBS, CYSLTR1 NOD1 419/4885FAAH 1433/4885MEN1 4534/4885
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID NPPA, BCAT1, ANPEP NOD1 3434/4885FAAH 858/4885MEN1 2101/4885
US-20040156802-A1 Cosmetics or external preparations for skin CUTA, PSAP, CTH NOD1 3684/4885FAAH 981/4885MEN1 2838/4885
US-20070099888-A1 Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid NFKBIA, ZNF787, IL17A NOD1 2459/4885FAAH 559/4885MEN1 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.